Morgan Stanley Investment Management Company and 10 related parties acquired 3% stake in Naturalendo Tech Co., Ltd..
May 06, 2015 at 12:00 am EDT
Share
Morgan Stanley Investment Management Company and 10 related parties acquired 3% stake in Naturalendo Tech Co., Ltd. (KOSDAQ:A168330) on May 6, 2015.
Morgan Stanley Investment Management Company and 10 related parties completed the acquisition of 3% stake in Naturalendo Tech Co., Ltd. (KOSDAQ:A168330) on May 6, 2015.
Naturalendo Tech Co.,Ltd. is a Korea-based company principally engaged in the research and development (R&D) and manufacture of hormone biotechnology products. The Company mainly provides novel phytoestrogen, which is applied in the treatment of climacteric. It also provides other hormonal formula, such as hormone disruptor inhibitor, secretagogue and inhibitor used as diet formula and growth hormone. In addition, the Company provides materials used for diet, and involves in the R&D of drug delivery systems, immune enhancer, atopy and acne, plantation factory, and others.
NATURALENDO TECH CO., LTD. 
